Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore

OBJECTIVE: To evaluate the cost-effectiveness of olaparib as a maintenance treatment versus routine surveillance (RS) in patients with BRCA mutated (BRCAm) advanced ovarian cancer (OC) following response to first-line platinum-based chemotherapy in Singapore. METHODS: A 4-health state partitioned su...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, David SP, Chan, Jack Junjie, Hettle, Robert, Ghosh, Wrik, Viswambaram, Amrita, Yu, Cindy Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930440/
https://www.ncbi.nlm.nih.gov/pubmed/33559410
http://dx.doi.org/10.3802/jgo.2021.32.e27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930440/
https://www.ncbi.nlm.nih.gov/pubmed/33559410
http://dx.doi.org/10.3802/jgo.2021.32.e27

Ejemplares similares